Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere?

Sean G. Kelly, Amesika N. Nyaku, Babafemi O. Taiwo*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The advent of combination antiretroviral therapy (ART) has significantly decreased AIDS-related morbidity and mortality. Nevertheless, the benefits of ART are only realized through adherence to lifelong treatment. Though contemporary antiretroviral (ARV) drugs have fewer adverse effects in comparison to older ARV drugs, many agents are associated with negative or unknown long-term effects. There is increasing evidence that two-drug (dual-therapy) regimens may be an effective alternative to the currently recommended three-drug (triple-therapy) regimens. In this review, we provide a comprehensive and critical review of recently completed and ongoing trials of dual-therapy regimens in treatment-naïve and treatment-experienced HIV-1-infected patients. We also review current HIV/AIDS society recommendations regarding dual therapy as well as future therapeutic possibilities.

Original languageEnglish (US)
Pages (from-to)523-531
Number of pages9
JournalDrugs
Volume76
Issue number5
DOIs
StatePublished - Apr 2016

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere?'. Together they form a unique fingerprint.

Cite this